Cure Rare Disease
Total Awards:
2
Award Value:
$13,043,134
Institution type:
Not for profit
Short Name:
Cure Rare Disease
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Preclinical Stage Projects | Dr. Tahseen Mozaffar | Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 | $7,350,596 |
| Late Stage Preclinical Projects | Dr. Susan Perlman | Advancing a novel antisense oligonucleotide for the treatment of SCA3, a devastating neurodegenerative disease | $5,692,538 |
| Total: $13,043,134.00 |
